KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Change in Cash (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Change in Cash for 18 consecutive years, with -$153.1 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Cash fell 125.35% year-over-year to -$153.1 million; the TTM value through Mar 2026 reached -$122.4 million, down 125.33%, while the annual FY2025 figure was $634.7 million, 355.1% up from the prior year.
  • Change in Cash hit -$153.1 million in Q1 2026 for Regeneron Pharmaceuticals, down from $610.6 million in the prior quarter.
  • Across five years, Change in Cash topped out at $809.4 million in Q1 2023 and bottomed at -$2.0 billion in Q2 2023.
  • Average Change in Cash over 5 years is $4.3 million, with a median of $96.2 million recorded in 2022.
  • Year-over-year, Change in Cash plummeted 4106.28% in 2023 and then soared 571.88% in 2025.
  • Regeneron Pharmaceuticals' Change in Cash stood at -$385.4 million in 2022, then surged by 249.87% to $577.6 million in 2023, then fell by 17.38% to $477.2 million in 2024, then increased by 27.95% to $610.6 million in 2025, then tumbled by 125.07% to -$153.1 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$153.1 million, $610.6 million, and $497.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.